Gainers & Losers
Fri Mar 13 2026 09:55:44- Hindustan Unilever share price
- ₹2,163.301.30%
- Bharti Airtel share price
- ₹1,806.700.33%
Active Stocks
Fri Mar 13 2026 10:25:25- Yes Bank share price
- ₹18.81-2.59%
- Suzlon Energy share price
- ₹41.40-2.50%
- Tata Motors Passenger Vehi...
- ₹314.30-3.13%
- Eternal share price
- ₹216.00-2.37%
- Adani Power share price
- ₹146.70-1.61%
Business News/Market/Market Stats/Eris Lifesciences share price/ Eris Lifesciences Balance Sheet Annual
Eris Lifesciences Balance Sheet Annual
1,316.65 -34.35 (-2.54%)Updated : 13 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 7,033.17 | 7,040.46 | 3,667.33 | 2,272.14 |
| Accumulated Depreciation Total | -221.31 | -145.04 | -93.37 | -74.99 |
| Other Liabilities Total | 79.85 | 60.38 | 62.36 | 37.80 |
| Accrued Expenses | 149.23 | 59.65 | 2.74 | - |
| Long Term Debt | 1,737.51 | 654.51 | 644.45 | 45.00 |
| Common Stock Total | 13.62 | 13.60 | 13.60 | 13.59 |
| Other Current Assets Total | 25.50 | 63.87 | 2.58 | 4.45 |
| Prepaid Expenses | 20.04 | 25.62 | 17.28 | 21.44 |
| Total Assets | 7,033.17 | 7,040.46 | 3,667.33 | 2,272.14 |
| Current Portof LT Debt/ Capital Leases | 299.61 | 340.93 | 138.28 | 4.00 |
| Additional Paid- In Capital | 29.34 | 18.07 | 15.10 | 10.61 |
| Cash | 199.64 | 94.14 | 56.02 | 50.87 |
| Total Equity | 2,854.36 | 2,586.18 | 2,195.99 | 1,908.31 |
| Long Term Investments | 62.20 | 15.73 | 6.88 | 420.84 |
| Retained Earnings( Accumulated Deficit) | 2,811.40 | 2,554.51 | 2,167.29 | 1,884.11 |
| Total Common Shares Outstanding | 13.62 | 13.60 | 13.60 | 13.59 |
| Property/ Plant/ Equipment Total- Gross | 950.11 | 703.35 | 470.75 | 266.84 |
| Tangible Book Valueper Share Common Eq | -131.48 | -87.80 | -1.21 | 84.99 |
| Goodwill Net | 911.97 | 867.17 | 331.85 | 93.47 |
| Total Liabilities | 4,178.81 | 4,454.28 | 1,471.34 | 363.83 |
| Total Debt | 2,477.92 | 2,781.27 | 876.71 | 84.41 |
| Short Term Investments | 5.73 | 1,244.61 | 30.01 | 99.55 |
| Cashand Short Term Investments | 205.37 | 1,338.75 | 86.03 | 150.42 |
| Total Receivables Net | 582.48 | 571.18 | 459.32 | 271.27 |
| Notes Payable/ Short Term Debt | 396.59 | 1,748.81 | 55.01 | 0.01 |
| Deferred Income Tax | 518.45 | 534.39 | 257.64 | 46.09 |
| Accounts Receivable- Trade Net | 458.64 | 422.08 | 287.96 | 157.98 |
| Property/ Plant/ Equipment Total- Net | 728.81 | 558.31 | 377.38 | 191.86 |
| Minority Interest | 417.40 | 635.91 | 24.69 | -0.11 |
| Total Current Liabilities | 1,381.39 | 2,532.07 | 443.23 | 199.65 |
| Total Inventory | 389.60 | 302.62 | 199.51 | 179.75 |
| Accounts Payable | 332.35 | 218.93 | 124.77 | 117.77 |
| Other Currentliabilities Total | 203.61 | 163.75 | 122.44 | 77.86 |
| Total Long Term Debt | 1,781.72 | 691.53 | 683.42 | 80.39 |
| Intangibles Net | 3,732.71 | 2,913.35 | 1,880.60 | 659.60 |
| Other Long Term Assets Total | 301.80 | 318.18 | 300.39 | 271.97 |
| Note Receivable- Long Term | 72.69 | 65.68 | 5.51 | 7.06 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,222.99 | 2,302.04 | 764.72 | 627.33 |
| Capital Lease Obligations | 44.21 | 37.02 | 38.97 | 35.39 |
*All figures in crores except per share values
Eris Lifesciences Quick Links
Eris Lifesciences Dividend Eris Lifesciences Bonus Eris Lifesciences News Eris Lifesciences AGM Eris Lifesciences Rights Eris Lifesciences Splits Eris Lifesciences Board Meetings Eris Lifesciences Key Metrics Eris Lifesciences Shareholdings Eris Lifesciences Profit Loss Eris Lifesciences Cashflow Eris Lifesciences Q1 Results Eris Lifesciences Q2 Results Eris Lifesciences Q3 Results Eris Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,184.40+48.95(2.29%)
3,568.35+36.20(1.02%)
1,814.30+13.50(0.75%)
3,575.85-145.10 (-3.90%)
186.35-7.10 (-3.67%)